Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

PaperCitations, authors & open-access status

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 184 citations, 2021 year and hybrid oa status.

184
Citations
2021
Year
hybrid
OA Status

Related on ScholarIQ

Martin Wermke
Author
Acute Myeloid Leukemia Research
Topic
Acute Myeloid Leukemia Research
Topic
Blood disorders and treatments
Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Topic
470M+ articles · free account